LEXINGTON, Mass.--(BUSINESS WIRE)--Pulmatrix Inc., a respiratory disease therapeutics company, announced today that Robert Connelly has joined as CEO. Connelly was formerly the founding CEO of Domantis, a biotechnology company acquired by GlaxoSmithKline in 2007. He succeeds Pulmatrix's founding CEO Mark Gabrielson, who remains a Director of the company.
